VALIDATION OF THE PCA3 MOLECULAR URINE TEST FOR PREDICTING REPEAT PROSTATE BIOPSY OUTCOME IN THE PLACEBO ARM OF THE DUTASTERIDE REDUCE TRIAL

被引：0
|
作者：
Marks, Leonard
Aubin, Sheila
Reid, Jennifer
Sarno, Mark
Blase, Amy
Aussie, Jacqueline
Rittenhouse, Harry
Andriole, Gerald
Rittmaster, Roger
Groskopf, Jack
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.2207
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2119
引用
收藏
页码：E823 / E823
页数：1
相关论文
共 50 条
  • [21] Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients
    Goode, Roland R.
    Marshall, Susan J.
    Duff, Michael
    Chevli, Eric
    Chevli, K. Kent
    PROSTATE, 2013, 73 (01): : 48 - 53
  • [22] Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
    Ferro, Matteo
    Bruzzese, Dario
    Perdona, Sisto
    Mazzarella, Claudia
    Marino, Ada
    Sorrentino, Alessandra
    Di Carlo, Angelina
    Autorino, Riccardo
    Di Lorenzo, Giuseppe
    Buonerba, Carlo
    Altieri, Vincenzo
    Mariano, Angela
    Macchia, Vincenzo
    Terracciano, Daniela
    CLINICA CHIMICA ACTA, 2012, 413 (15-16) : 1274 - 1278
  • [23] PREDICTING PROSTATE BIOPSY OUTCOME: PROSTATE HEALTH INDEX (PHI) AND PROSTATE CANCER ANTIGEN 3 (PCA3) ARE USEFUL BIOMARKERS
    Ferro, Matteo
    Montanaro, Vittorino
    Marsicano, Mariano
    Capece, Marco
    Terracciano, Daniela
    Sorrentino, Alessandra
    Marino, Ada
    Quarto, Giuseppe
    De Domenico, Renato
    Sorrentino, Domenico
    Altieri, Vincenzo
    Perdona, Sisto
    ANTICANCER RESEARCH, 2012, 32 (05) : 1940 - 1941
  • [24] PCA3 REPRESENTS A CLINICALLY MEANINGFUL PREDICTOR OF PROSTATE CANCER AT REPEAT BIOPSY
    Haese, A.
    Chun, F.
    de la Taille, A.
    van Poppel, H.
    Marberger, M.
    Mulders, P.
    Abbou, C. -C.
    Stenzl, A.
    Huland, H.
    Tinzl, M.
    Remzi, M.
    Feyerabend, S.
    Van Gils, M.
    Stillebroer, A.
    Schalken, J.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4053 - 4054
  • [25] PCA3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy
    Okihara, K.
    Ochial, A.
    Fros, Z.
    Miki, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] PCA3 COMPARISON WITH PROSTATE HEALTH INDEX (PHI) IN REPEAT BIOPSY PATIENTS
    Perdona, Sisto
    Ferro, Matteo
    Perruolo, Giuseppe
    Formisano, Pietro
    Portella, Giuseppe
    Badi, Ermanno
    Longo, Michele
    Di Lorenzo, Giuseppe
    Autorino, Riccardo
    Altieri, Vincenzo
    Terracciano, Daniela
    ANTICANCER RESEARCH, 2011, 31 (05) : 1918 - 1918
  • [27] PCA3 represents a clinically meaningful predictor of prostate cancer at repeat biopsy
    Haese, A.
    Chun, F.
    De La Taille, A.
    Van Poppel, H.
    Marberger, M.
    Mulders, P.
    Abbou, C. C.
    Stenzl, A.
    Huland, H.
    Tinzi, M.
    Remzi, M.
    Feyeralbend, S.
    Van Gils, M.
    Stillebroer, A.
    Schalken, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 140 - 140
  • [28] APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer
    Groskopf, Jack
    Aubin, Sheila M. J.
    Deras, Ina Lim
    Blase, Amy
    Bodrug, Sharon
    Clark, Craig
    Brentano, Steven
    Mathis, Jeannette
    Pham, Jimmykim
    Meyer, Troels
    Cass, Michelle
    Hodge, Petrea
    Macairan, Maria Luz
    Marks, Leonard S.
    Rittenhouse, Harry
    CLINICAL CHEMISTRY, 2006, 52 (06) : 1089 - 1095
  • [29] APTIMA® PCA3 molecular urine test:: Development of a method to aid in the diagnosis of prostate cancer
    Clark, CB
    Rittenhouse, H
    Bodrug, S
    Brentano, S
    Rasmussen, E
    Mathis, J
    Pham, J
    Desaulniers, M
    Beaudry, G
    Chypre, C
    Piche, L
    Fredet, Y
    CLINICAL CHEMISTRY, 2005, 51 : A61 - A61
  • [30] APTIMA® PCA3 molecular urine test:: Development of a method to aid in the diagnosis of prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 275 - 275
12345